aTyr Pharma Announces Third Quarter 2015 Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
aTyr Pharma (LIFE) Trims Q3 Loss
November 11, 2015 7:38 AM ESTaTyr Pharma (NASDAQ: LIFE) reported Q3 EPS of ($0.48), versus ($8.02) reported last year.
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.
... MoreaTyr Pharma (LIFE) Selects iMod.Fc Molecule as IND Candidate
November 11, 2015 7:37 AM ESTaTyr Pharma (NASDAQ: LIFE) announced that it has selected an Investigational New Drug (IND) Candidate based on an immuno-modulatory and fibro-modulating Physiocrine domain fused to an Fc region of a human antibody, iMod.Fc. The selected iMod.Fc molecule is intended to address patients with severe pulmonary diseases with an immune and fibrotic component.
"The molecule developed in our iMod.Fc discovery program represents a major breakthrough as the first engineered Physiocrine with advantageous pharmaceutical properties... More
